AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

NewGenIvf Group Limited

$1.06 -$71.30 (-98.54%)
NASDAQ · 11 Sep 2026 20:00 UTC
Previous Close
$1.11
Day Range
$1.05$1.15
Year Range
$1.02$1539
Market Cap
66.96K
AVG Volume
502.77K
Trailing/Forward PE
0.01/0.01
PEG ratio
0
Dividend Yield
-
Next Earnings Date
2027-03-03
Primary Exchange
NASDAQUS
Revenue (USD)
0500K1M1.5M2M22 Q322 Q423 Q123 Q223 Q323 Q424 Q324 Q425 Q325 Q4
NIVF Revenue (USD) by quarter
PeriodRevenue (USD)
25 Q41.42M
25 Q31.28M
24 Q41.27M
24 Q31.47M
23 Q41.52M
23 Q30
23 Q20
23 Q10
22 Q40
22 Q30
Net Income (USD)
-10M010M20M22 Q322 Q423 Q123 Q223 Q323 Q424 Q324 Q425 Q325 Q4
NIVF Net Income (USD) by quarter
PeriodNet Income (USD)
25 Q4-7.67M
25 Q316.82M
24 Q4-108K
24 Q3-19.86K
23 Q4335.62K
23 Q3127.02K
23 Q285.5K
23 Q152.12K
22 Q4474.36K
22 Q3208.32K
Operating Income (USD)
-6M-4M-2M02M22 Q322 Q423 Q123 Q223 Q323 Q424 Q324 Q425 Q325 Q4
NIVF Operating Income (USD) by quarter
PeriodOperating Income (USD)
25 Q4-4.97M
25 Q3-2.51M
24 Q4-1.09M
24 Q3216.31K
23 Q4196.82K
23 Q3-377.72K
23 Q2-367K
23 Q1-510.55K
22 Q4-115.64K
22 Q3-106.55K
EBITDA (USD)
-10M010M20M22 Q322 Q423 Q123 Q223 Q323 Q424 Q324 Q425 Q325 Q4
NIVF EBITDA (USD) by quarter
PeriodEBITDA (USD)
25 Q4-7.27M
25 Q316.8M
24 Q458.33K
24 Q3226.87K
23 Q4363.77K
23 Q3127.02K
23 Q285.5K
23 Q152.12K
22 Q4474.36K
22 Q3208.32K
Cash Flows (USD)
-8M-6M-4M-2M022 Q322 Q423 Q323 Q424 Q4
NIVF Cash Flows (USD) by quarter
PeriodCash Flows (USD)
24 Q4-6.36M
23 Q4-142.71K
23 Q3-203.28K
22 Q4-34.67K
22 Q3-22.7K
EPS (USD)
-200-100010020030022 Q322 Q423 Q123 Q223 Q323 Q424 Q324 Q425 Q325 Q4
NIVF EPS (USD) by quarter
PeriodEPS (USD)
25 Q4-117.36
25 Q3257.4
24 Q4-13.79
24 Q3-3.92
23 Q495.95
23 Q368.08
23 Q245.73
23 Q127.87
22 Q4158.37
22 Q369.53
Expenses (USD)
-2M02M4M6MSG&ACapex22 Q322 Q423 Q123 Q223 Q323 Q424 Q324 Q425 Q325 Q4
NIVF Expenses (USD) by quarter
PeriodExpenses (USD)
25 Q45.5M
25 Q32.63M
24 Q41.63M
24 Q3432.52K
23 Q41.27M
23 Q3377.72K
23 Q2367K
23 Q1510.55K
22 Q4115.64K
22 Q3106.55K
Cash & Debt (USD)
010M20M30M40MCashLong Term DebtShort Term Debt21 Q221 Q322 Q423 Q223 Q323 Q424 Q324 Q425 Q325 Q4
NIVF Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
25 Q4758.62K
25 Q3295.29K
24 Q4457.74K
24 Q3169.66K
23 Q454.1K
23 Q339.29M
23 Q277.29K
22 Q427.56K
21 Q30
21 Q20
Debt ratios
-60-40-2002022 Q423 Q223 Q323 Q424 Q324 Q425 Q325 Q4
NIVF Debt ratios by quarter
PeriodDebt ratios
25 Q40.42
25 Q30.3
24 Q43.31
24 Q36.35
23 Q40.44
23 Q3-51.25
23 Q20.34
22 Q40.85
Margins
0%20%40%60%23 Q424 Q324 Q425 Q325 Q4
NIVF Margins by quarter
PeriodMargins
25 Q436.79%
25 Q39.2%
24 Q442.33%
24 Q344.05%
23 Q412.95%
Return on Capital
-200%0%200%400%600%21 Q221 Q322 Q423 Q223 Q323 Q424 Q324 Q425 Q325 Q4
NIVF Return on Capital by quarter
PeriodReturn on Capital
25 Q4-29.51%
25 Q358.54%
24 Q48.45%
24 Q30.28%
23 Q410.34%
23 Q30.36%
23 Q2-178.48%
22 Q4471.14%
21 Q3-0.35%
21 Q2-8.74%
Shares Outstanding
050K100K150K200K22 Q322 Q423 Q123 Q223 Q323 Q424 Q324 Q425 Q325 Q4
NIVF Shares Outstanding by quarter
PeriodShares Outstanding
25 Q465.36K
25 Q365.36K
24 Q4196.08K
24 Q387.4K
23 Q487.4K
23 Q387.4K
23 Q287.4K
23 Q187.4K
22 Q487.4K
22 Q387.4K
Book Value Per Share (USD)
-200020040060021 Q221 Q322 Q423 Q223 Q323 Q424 Q324 Q425 Q325 Q4
NIVF Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
25 Q4397.6
25 Q3439.72
24 Q4-6.52
24 Q3-80.95
23 Q437.14
23 Q3399.42
23 Q2-0.55
22 Q41.15
21 Q30.26
21 Q20.26
Total Assets (USD)
010M20M30M40M21 Q221 Q322 Q423 Q223 Q323 Q424 Q324 Q425 Q325 Q4
NIVF Total Assets (USD) by quarter
PeriodTotal Assets (USD)
25 Q432.72M
25 Q335.56M
24 Q43.78M
24 Q31.47M
23 Q44.49M
23 Q339.34M
23 Q21.45M
22 Q42.9M
21 Q3245.21K
21 Q2139.75K
Employee Count
02550751002023202420242025
NIVF Employee Count by quarter
PeriodEmployee Count
202587
202476
202463
202370
PE Ratio
0250005000075000100000med 566.11Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
NIVF PE Ratio by quarter
PeriodPE Ratio
Sep 260.01
Sep 260.01
Aug 260.01
Aug 260.01
Aug 260.01
Aug 260.01
Jul 260.02
Jul 260.02
Jul 260.03
Jul 260.03
Jul 260.03
Jun 260.04
Jun 260.05
Jun 260.04
Jun 260.04
May 260.06
May 260.07
May 260.06
May 260.08
May 260.11
Apr 260.13
Apr 260.15
Apr 260.13
Apr 260.14
Mar 260.06
Mar 260.06
Mar 260.08
Mar 260.07
Feb 260.11
Feb 260.12
Feb 260.11
Feb 260.14
Jan 260.19
Jan 260.21
Jan 260.23
Jan 260.25
Jan 260.28
Dec 250.33
Dec 250.37
Dec 250.44
Dec 250.6
Nov 250.74
Nov 250.63
Nov 250.78
Nov 250.99
Oct 251.57
Oct 252.53
Oct 252.55
Oct 253.75
Oct 25581.93
Sep 25581.93
Sep 25594.58
Sep 25623.04
Sep 25578.77
Aug 25594.58
Aug 25553.46
Aug 25600.9
Aug 25591.42
Aug 25632.53
Jul 25822.29
Jul 25898.19
Jul 25991.49
Jul 251464.31
Jun 251628.77
Jun 251897.59
Jun 252688.25
Jun 253478.92
May 253194.28
May 254174.7
May 254664.91
May 255344.88
May 254759.79
Apr 255534.64
Apr 251264.09
Apr 251795.63
Apr 252027.9
Mar 254198.74
Mar 254377.41
Mar 254779.42
Mar 255538.76
Feb 259201.5
Feb 259424.83
Feb 258710.15
Feb 2511970.88
Jan 2513310.9
Jan 2523673.75
Jan 2531177.88
Jan 2533053.92
Jan 2535376.62
Dec 2438235.34
Dec 2429748.52
Dec 2428319.17
Dec 2440022.04
Nov 2429480.52
Nov 2440019.02
Nov 2451183.47
Nov 2458180.9
Nov 2458259.52
Oct 2470760.55
Oct 2494347.4
Price to Sales
010000200003000040000med 44.43Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
NIVF Price to Sales by quarter
PeriodPrice to Sales
Sep 260.01
Sep 260.01
Aug 260.02
Aug 260.02
Aug 260.02
Aug 260.02
Jul 260.03
Jul 260.04
Jul 260.05
Jul 260.05
Jul 260.05
Jun 260.06
Jun 260.08
Jun 260.06
Jun 260.07
May 260.1
May 260.11
May 260.1
May 260.13
May 260.18
Apr 260.21
Apr 260.25
Apr 260.22
Apr 260.23
Mar 260.2
Mar 260.17
Mar 260.24
Mar 260.21
Feb 260.35
Feb 260.36
Feb 260.34
Feb 260.42
Jan 260.58
Jan 260.64
Jan 260.71
Jan 260.76
Jan 260.85
Dec 251.02
Dec 251.14
Dec 251.34
Dec 251.84
Nov 252.26
Nov 251.92
Nov 252.4
Nov 253.05
Oct 254.83
Oct 257.76
Oct 257.82
Oct 2511.51
Oct 2545.67
Sep 2545.67
Sep 2546.66
Sep 2548.9
Sep 2545.42
Aug 2546.66
Aug 2543.44
Aug 2547.16
Aug 2546.41
Aug 2549.64
Jul 2564.53
Jul 2570.49
Jul 2577.81
Jul 25114.92
Jun 25127.83
Jun 25148.92
Jun 25210.97
Jun 25273.02
May 25250.69
May 25327.63
May 25366.1
May 25419.47
May 25373.55
Apr 25434.36
Apr 25223.17
Apr 25317.01
Apr 25358.02
Mar 25741.28
Mar 25772.82
Mar 25843.79
Mar 25977.86
Feb 251624.5
Feb 251663.93
Feb 251537.76
Feb 252113.43
Jan 252350.01
Jan 254179.54
Jan 255504.38
Jan 255835.59
Jan 256245.66
Dec 246750.35
Dec 245252.03
Dec 244999.68
Dec 247065.79
Nov 245204.71
Nov 2415809.58
Nov 2420220.11
Nov 2422984.45
Nov 2423015.51
Oct 2427954.06
Oct 2437272.09
EV/EBITDA
0250005000075000100000med 247.56Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
NIVF EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 260.43
Sep 260.43
Aug 260.43
Aug 260.43
Aug 260.43
Aug 260.43
Jul 260.43
Jul 260.44
Jul 260.45
Jul 260.45
Jul 260.45
Jun 260.45
Jun 260.46
Jun 260.45
Jun 260.46
May 260.47
May 260.48
May 260.47
May 260.49
May 260.52
Apr 260.54
Apr 260.56
Apr 260.54
Apr 260.55
Mar 260.36
Mar 260.35
Mar 260.38
Mar 260.36
Feb 260.41
Feb 260.41
Feb 260.41
Feb 260.43
Jan 260.48
Jan 260.5
Jan 260.53
Jan 260.54
Jan 260.57
Dec 250.62
Dec 250.66
Dec 250.72
Dec 250.89
Nov 251.02
Nov 250.91
Nov 251.06
Nov 251.27
Oct 251.84
Oct 252.77
Oct 252.79
Oct 253.96
Oct 25254.38
Sep 25254.38
Sep 25259.84
Sep 25272.12
Sep 25253.01
Aug 25259.84
Aug 25242.1
Aug 25262.56
Aug 25258.47
Aug 25276.21
Jul 25358.08
Jul 25390.83
Jul 25431.08
Jul 25635.07
Jun 25706.02
Jun 25822
Jun 251163.12
Jun 251504.23
May 251381.43
May 251804.42
May 252015.91
May 252309.27
May 252056.85
Apr 252391.14
Apr 25837.82
Apr 251187.44
Apr 251340.22
Mar 252768.11
Mar 252885.63
Mar 253150.05
Mar 253649.52
Feb 256058.71
Feb 256205.61
Feb 255735.52
Feb 257880.29
Jan 258761.7
Jan 2515577.94
Jan 2520513.84
Jan 2521747.82
Jan 2523275.6
Dec 2425155.94
Dec 2419573.67
Dec 2418633.5
Dec 2426331.16
Nov 2419397.39
Nov 2438226.86
Nov 2448891.2
Nov 2455575.2
Nov 2455650.3
Oct 2467591.36
Oct 2490121.66
Price to Book
05000100001500020000med 1088.32Feb 24May 24Sep 24Oct 25Feb 26May 26Sep 26
NIVF Price to Book by quarter
PeriodPrice to Book
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260.01
Jul 260.01
Jul 260.01
Jul 260.01
Jul 260.01
Jun 260.01
Jun 260.02
Jun 260.01
Jun 260.01
May 260.02
May 260.02
May 260.02
May 260.03
May 260.04
Apr 260.04
Apr 260.05
Apr 260.05
Apr 260.05
Mar 260.04
Mar 260.03
Mar 260.05
Mar 260.04
Feb 260.07
Feb 260.07
Feb 260.07
Feb 260.08
Jan 260.11
Jan 260.12
Jan 260.14
Jan 260.15
Jan 260.16
Dec 250.2
Dec 250.22
Dec 250.26
Dec 250.36
Nov 250.44
Nov 250.37
Nov 250.46
Nov 250.59
Oct 250.93
Oct 251.5
Oct 251.51
Oct 252.22
Nov 247401.48
Nov 249466.33
Nov 2410760.49
Nov 2410775.04
Oct 2413087.09
Oct 2417449.45
Oct 2414250.38
Oct 249858.94
Sep 249073.71
Sep 249408.16
Sep 2410164.3
Sep 249902.56
Aug 2412505.44
Aug 2416489.73
Aug 241151.86
Aug 241135.64
Aug 241178.9
Jul 241392.51
Jul 241243.79
Jul 241378.99
Jul 241305.98
Jun 241324.91
Jun 241419.54
Jun 241406.03
Jun 241554.74
May 241852.17
May 241433.06
May 241527.7
May 241730.49
May 241635.86
Apr 242406.47
Apr 241041
Apr 241164.03
Apr 241351.95
Mar 2412748.87
Mar 2412275.68
Mar 2414871.42
Mar 2416683.03
Mar 2413249.09
Feb 2414979.58
Feb 2414911.98
Feb 2414884.94
Feb 2414844.38
Jan 2414844.38
Jan 2414830.86
Jan 2414790.31
Jan 2414736.23
Dec 2314736.23
Dec 2314749.75
Dec 2314736.23
Dec 2314722.71
NewGenIvf Group Limited
NIVF
Stockpicker

Video analysis: NIVF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: NIVF

NewGenIVF Completes Exchange of Convertible Notes with Institutional Investor

globenewswire.com · 17 Aug 2026

NewGenIVF Completes Exchange of Convertible Notes with Institutional Investor

BANGKOK, Aug. 17, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today announced that it has completed an exchange agreement with a certain institutional investor (“Investor”) pursuant to which existing convertible notes held by the Investor were exchanged for a new senior convertible note on amended terms. The exchange closed on August 14, 2026.

NewGen Provides Update on K25.ai Investment and Strengthened Financial Position

globenewswire.com · 30 Jul 2026

NewGen Provides Update on K25.ai Investment and Strengthened Financial Position

NewGen's total shares outstanding count expected to reach 5.9 million following recently announced share issuance, bolstering market capitalization NewGen's agreed 13% stake in K25.ai is now valued at approximately US$26 million, based on K25.ai's recently closed Series A investment round, representing an unrealized gain of about US$8.5 million BANGKOK, July 30, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today provided an update on its strategic investment in K25.ai and the related impact on the Company's capitalization and financial position. NewGen reported net profit attributable to shareholders of US$9.9 million for the fiscal year ended December 31, 2025, with net assets of approximately US$25.98 million as of that date.

NewGen to Acquire Additional 3% of K25.ai at US$250 Million Valuation Following Strong Community Beta; Strengthening Market Cap Above US$5 Million

globenewswire.com · 27 Jul 2026

NewGen to Acquire Additional 3% of K25.ai at US$250 Million Valuation Following Strong Community Beta; Strengthening Market Cap Above US$5 Million

Follow-on investment would increase NewGen's aggregate ownership to 13% Follow-on investment would increase NewGen's aggregate ownership to 13%

NewGen's Strategic Pre-A Investment in K25.ai Doubles in Value as K25.ai's Valuation Reaches US$200 Million

globenewswire.com · 23 Jul 2026

NewGen's Strategic Pre-A Investment in K25.ai Doubles in Value as K25.ai's Valuation Reaches US$200 Million

K25.ai closes Series A investment round, reaching a post-money valuation of US$200 million NewGen's 10% ownership stake in K25.ai has reached US$20 million in value and generated a ~US$10 million unrealized gain, expected to be booked in 2026 BANGKOK, July 23, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today highlighted that K25.ai has closed its Series A investment round with strategic support from the Singapore-based digital assets firm Amber Group. The latest round values K25.ai at a post-money valuation of US$200 million, doubling its US$100 million Pre-A valuation in under 60 days.

K25.ai Secures Series A Investment with Strategic Support from Amber Group, Valuation Doubles to US$200 Million

prnewswire.com · 23 Jul 2026

K25.ai Secures Series A Investment with Strategic Support from Amber Group, Valuation Doubles to US$200 Million

/PRNewswire/ -- K25.ai, the AI-native prediction market transforming livestreams into real-time interactive markets, today announced the closing of its Series

NewGen's Advanced Cytometry Platform Poised for Major UAE/GCC Expansion with Big Four Valuation of US$19 Million

globenewswire.com · 6 Jul 2026

NewGen's Advanced Cytometry Platform Poised for Major UAE/GCC Expansion with Big Four Valuation of US$19 Million

Midpoint equity value for planned UAE cell sorting entity highlights significant growth runway in high-infertility, medical-tourism hotspot

NewGen Issues 3,666,667 New Shares in Connection with Strategic K25.ai Acquisition, Reaches Milestone of US$7.6 Million Market Capitalization

globenewswire.com · 22 Jun 2026

NewGen Issues 3,666,667 New Shares in Connection with Strategic K25.ai Acquisition, Reaches Milestone of US$7.6 Million Market Capitalization

Strong Capitalization Foundation Supports Strategic Growth and Market Stability Strong Capitalization Foundation Supports Strategic Growth and Market Stability

NewGen Increases K25.ai Ownership to 10% in Closed Pre-A Round at US$100 Million Valuation with Total US$10 Million Invested

globenewswire.com · 18 Jun 2026

NewGen Increases K25.ai Ownership to 10% in Closed Pre-A Round at US$100 Million Valuation with Total US$10 Million Invested

K25.ai to complete its US$10 million Pre-A at a US$100 million valuation and is now raising its Series A to accelerate product launch and regional expansion

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.